Published in Br J Dis Chest on October 01, 1982
Transbronchial needle aspiration cytology (TBNA) in endobronchial lesions: a valuable technique during bronchoscopy in diagnosing lung cancer and it will decrease repeat bronchoscopy. J Cancer Res Clin Oncol (2014) 0.83
Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax (1984) 0.75
Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) (1982) 7.77
Oxygen relieves breathlessness in "pink puffers". Lancet (1981) 3.64
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet (1995) 3.59
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol (1999) 3.20
Pulmonary fibrosis associated with hypersensitivity to gold salts. Br Med J (1976) 2.91
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest (1979) 2.76
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) (1981) 2.74
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer (2005) 2.71
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19
Inhaled corticosteroids: benefits and risks. Thorax (1992) 2.17
Comparison of Mantoux, tine, and 'Imotest' tuberculin tests. Lancet (1982) 2.16
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg (2004) 2.14
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J (1994) 2.07
Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol (2005) 2.04
Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst (1997) 2.01
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
Recruitment of patients with lung cancer into a randomised clinical trial: experience at two centres. On behalf of the Big Lung Trial Steering Committee. Thorax (2000) 1.84
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene (1992) 1.84
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis (1981) 1.76
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci (1968) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Pseudo-steroid resistant asthma. Thorax (1999) 1.67
Portable oxygen therapy: assessment and usage. Respir Med (1991) 1.66
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J (2010) 1.65
Covered expandable metal stent for recurrent tracheal obstruction. Lancet (1990) 1.58
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis (1990) 1.57
BOOP and COP. Thorax (1991) 1.57
Simian virus 40 and human pleural mesothelioma. Thorax (1999) 1.56
Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet (1993) 1.55
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J (2001) 1.55
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
Malignant mesothelioma: predictors of prognosis and clinical trials. Thorax (2000) 1.46
Pleural mesothelioma resulting from exposure to amosite asbestos in a building. Respir Med (1989) 1.44
Collateral ventilation. Thorax (2006) 1.42
Inhaled corticosteroids: benefits and risks. J Asthma (1996) 1.39
Nedocromil sodium workshop. Respir Med (1989) 1.38
Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med (1992) 1.37
Treating patients with asthma who are dependent on systemic steroids. BMJ (1989) 1.37
Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type. Thorax (1982) 1.36
Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol (2000) 1.35
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
Airways obstruction in rheumatoid arthritis. Ann Rheum Dis (1979) 1.31
Newly diagnosed cystic fibrosis in middle and later life. Thorax (1985) 1.30
Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax (1982) 1.27
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1983) 1.23
Bronchography in the assessment of patients with lung collapse for endoscopic laser therapy. Thorax (1990) 1.20
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax (1988) 1.19
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet (1990) 1.14
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet (1993) 1.14
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax (1985) 1.12
The management of acute severe asthma. Postgrad Med J (1985) 1.11
Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax (1998) 1.11
Clinical evaluation of a serological assay using a monoclonal antibody (TB72) to the 38 kDa antigen of Mycobacterium tuberculosis. Eur Respir J (1994) 1.10
Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells. Br J Ind Med (1992) 1.10
High frequency oscillations improve nasal mucociliary transport. Lancet (1984) 1.08
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax (2000) 1.08
Case-referent survey of young adults with mesothelioma: I. Lung fibre analyses. Ann Occup Hyg (2001) 1.06
Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol (1985) 1.06
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. Lancet (1999) 1.05
Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax (1976) 1.04
Reproducibility of dynamically represented acoustic lung images from healthy individuals. Thorax (2007) 1.03
Depression of central respiratory drive by nitrazepam. Thorax (1978) 1.03
Erythromycin and diffuse panbronchiolitis. Thorax (1997) 1.03
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
The effect of isoprenaline on plasma renin activity in man: a dose-response curve. Clin Endocrinol (Oxf) (1977) 1.01
Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet (1984) 1.01
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep (1982) 1.01
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther (1999) 1.01
Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948). Br J Dis Chest (1983) 1.01